Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
5.77
+0.45 (8.46%)
At close: Aug 22, 2025, 4:00 PM
5.66
-0.11 (-1.91%)
After-hours: Aug 22, 2025, 7:59 PM EDT

Salarius Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
33332222
Upgrade
Market Cap Growth
34.12%3.58%-26.56%-84.44%3.42%41.29%
Upgrade
Enterprise Value
2-0-5-13-1013
Upgrade
Last Close Price
5.7727.6078.00183.601486.802730.00
Upgrade
PS Ratio
----12.174.14
Upgrade
PB Ratio
-1.750.480.340.580.98
Upgrade
P/TBV Ratio
-1.750.480.340.751.63
Upgrade
EV/Sales Ratio
-----2.46
Upgrade
Debt / Equity Ratio
-0.150.06--0.02
Upgrade
Asset Turnover
----0.060.27
Upgrade
Quick Ratio
0.361.614.543.2213.845.40
Upgrade
Current Ratio
0.611.985.023.4014.295.70
Upgrade
Return on Equity (ROE)
-660.37%-164.02%-160.07%-128.73%-41.94%-44.91%
Upgrade
Return on Assets (ROA)
-143.52%-74.59%-75.90%-51.76%-24.35%-25.07%
Upgrade
Return on Capital (ROIC)
-459.31%-98.05%-100.98%-58.48%-26.10%-28.86%
Upgrade
Earnings Yield
-173.53%-210.27%-489.96%-906.80%-56.99%-33.94%
Upgrade
FCF Yield
-140.88%-170.66%-501.81%-504.79%-45.53%-47.61%
Upgrade
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q